Marek Zygmunt

ORCID: 0000-0001-9058-9178 · 8 papers in corpus
other 2025
Journal of robotic surgery ·doi:10.1007/s11701-025-02983-1

INTRODUCTION: The Single-Port (SP) surgical system represents a significant advancement in robotic surgery, facilitating procedures through a single incision while overcoming the previously reported limitations of single-site surgery. As th…

other 2025
BMC cancer ·doi:10.1186/s12885-024-13396-y

BACKGROUND: The diagnosis of rare uterine leiomyosarcoma (uLMS) remains a challenge given the high incidence rates of benign uterine tumors such as leiomyoma (LM). In the last decade, several clinical scores and blood serum markers have bee…

case-report 2024
The American journal of case reports ·doi:10.12659/ajcr.943625

BACKGROUND Abdominal pregnancy is a rare form of extrauterine pregnancy that usually results in a poor outcome; it is associated with serious fetal and maternal morbidity. The diagnosis of advanced abdominal pregnancy is sometimes challengi…

observational 2024
Journal of clinical medicine ·doi:10.3390/jcm13144048

Background: There are conflicting data regarding the detection rate of high-risk uterine sarcoma (HRUS) by endometrial biopsy. In addition, there are no studies in the literature on its impact on the chosen surgical approach and survival. M…

2012
·doi:10.1055/s-0031-1298510

DNG hatte jedoch eine Reihe von endokrinologischen Eigenschaften, die die Substanz ganz speziell zur Behandlung der Endometriose qualifizierten. Dazu gehörten: spezifische Bindung an den Progesteronrezeptor, aber keine Bindung an Transportg…

lab-animal 2008
Reproductive medicine and biology ·doi:10.1111/j.1447-0578.2008.00213.x

Aim:  Endometrial tissue inhibitors of metalloproteinases (TIMPs) appear to play an essential role during early implantation by modulating the invasiveness of the trophoblast. The expression of TIMP-1, TIMP-2 and TIMP-3 in human endometrial…

review 2004
·doi:10.1055/s-2004-829721

Die Adenomyosis uteri wurde erstmals bereits 1890 durch Rokitansky beschreiben. Es wird angenommen, dass ca. 1% der weiblichen Population von der Erkrankung betroffen ist. Die Häufigkeit der Erkrankung liegt bei hysterektomierten Patientinn…

2004
·doi:10.1055/s-2004-828845